- Home
- LANC vs KTTA Comparison
LANC vs KTTA Comparison
Compare LANC & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANC
- KTTA
- Stock Information
- Founded
- LANC 1961
- KTTA 2020
- Country
- LANC United States
- KTTA United States
- Employees
- LANC N/A
- KTTA N/A
- Industry
- LANC Packaged Foods
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- LANC Consumer Staples
- KTTA Health Care
- Exchange
- LANC Nasdaq
- KTTA Nasdaq
- Market Cap
- LANC N/A
- KTTA 2.8M
- IPO Year
- LANC N/A
- KTTA 2021
- Fundamental
- Price
- LANC $171.46
- KTTA $0.72
- Analyst Decision
- LANC Buy
- KTTA
- Analyst Count
- LANC 4
- KTTA 0
- Target Price
- LANC $209.67
- KTTA N/A
- AVG Volume (30 Days)
- LANC 164.2K
- KTTA 192.8K
- Earning Date
- LANC 08-21-2025
- KTTA 08-12-2025
- Dividend Yield
- LANC 2.20%
- KTTA N/A
- EPS Growth
- LANC 27.36
- KTTA N/A
- EPS
- LANC 6.15
- KTTA N/A
- Revenue
- LANC $1,886,520,000.00
- KTTA N/A
- Revenue This Year
- LANC $3.16
- KTTA N/A
- Revenue Next Year
- LANC $2.33
- KTTA N/A
- P/E Ratio
- LANC $28.08
- KTTA N/A
- Revenue Growth
- LANC 0.69
- KTTA N/A
- 52 Week Low
- LANC $156.14
- KTTA $0.70
- 52 Week High
- LANC $202.63
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- LANC 54.29
- KTTA 33.76
- Support Level
- LANC $166.99
- KTTA $0.71
- Resistance Level
- LANC $172.70
- KTTA $0.76
- Average True Range (ATR)
- LANC 3.13
- KTTA 0.04
- MACD
- LANC 0.54
- KTTA 0.01
- Stochastic Oscillator
- LANC 75.67
- KTTA 8.59
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).